Group 1 - Citigroup (C) has experienced a significant downtrend, with a stock decline of 14.3% over the past four weeks, but it is now in oversold territory, indicating a potential for a turnaround [1] - The Relative Strength Index (RSI) is a key technical indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2] - Citigroup's current RSI reading is 27.35, suggesting that the heavy selling pressure may be exhausting itself, which could lead to a reversal in the stock's trend [5] Group 2 - There is a strong consensus among sell-side analysts regarding Citigroup's ability to report better earnings than previously predicted, with a 0% increase in the consensus EPS estimate over the last 30 days [6] - Citigroup holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, indicating a favorable outlook for a potential turnaround [7]

Core Viewpoint - PNC Financial Services Group, Inc has experienced significant selling pressure, resulting in a 9.3% decline in stock price over the past four weeks, but analysts anticipate better earnings than previously predicted, indicating potential for recovery [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) for PNC is currently at 29.71, suggesting that the stock is in oversold territory and may be poised for a rebound as selling pressure exhausts [5] - RSI is a momentum oscillator that helps identify whether a stock is overbought or oversold, with readings below 30 typically indicating oversold conditions [2][3] Group 2: Fundamental Indicators - There has been a consensus among sell-side analysts to raise earnings estimates for PNC, resulting in a 0.5% increase in the consensus EPS estimate over the last 30 days, which often correlates with price appreciation [6] - PNC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [7]

Core Viewpoint - JD.com is set to report its fourth-quarter earnings, with Wall Street expecting earnings per share (EPS) of 80 cents and revenues of $45.16 billion, indicating strong market anticipation for the results [1] Group 1: Stock Performance - JD.com stock has increased by 101.96% over the past year and 26.50% year-to-date [1] - The current stock price is $42.94, which is above key support levels, including the eight-day simple moving average at $41.31, the 20-day at $40.77, and the 50-day at $38.56, indicating a strong bullish trend [2] - The stock is also well above its 200-day simple moving average of $33.89, suggesting strong long-term support [3] Group 2: Technical Indicators - The Moving Average Convergence Divergence (MACD) indicator is at 0.78, indicating continued upward momentum [3] - The Relative Strength Index (RSI) is at 57.75, suggesting the stock is in neutral territory, allowing for further gains [3] Group 3: Analyst Ratings and Price Targets - The consensus analyst rating for JD.com stock is currently a Buy, with a price target of $42 [4] - Analysts from Barclays, Bernstein, and Citigroup have an average price target of $50.67, implying a potential upside of 16.76% for the stock [4] - At the time of publication, JD.com stock was up 6.35% at $43.55 [4]

Group 1 - Accel Entertainment (ACEL) has experienced a significant decline of 10.6% over the past four weeks, but it is now in oversold territory, indicating a potential trend reversal [1] - The Relative Strength Index (RSI) for ACEL is currently at 28.82, suggesting that the heavy selling pressure may be exhausting itself [5] - There is strong consensus among Wall Street analysts that ACEL will report better earnings than previously predicted, with a 23.7% increase in the consensus EPS estimate over the last 30 days [6] Group 2 - ACEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [7]

Core Viewpoint - Relay Therapeutics, Inc. (RLAY) has experienced a significant decline of 31.1% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from Wall Street analysts [1]. Group 1: Stock Performance and Technical Indicators - RLAY's stock has been under heavy selling pressure, leading to an RSI reading of 26.89, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Earnings Estimates and Analyst Consensus - There is a strong consensus among sell-side analysts that RLAY will report better earnings than previously predicted, with a 14.1% increase in the consensus EPS estimate over the last 30 days [6]. - RLAY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a near-term turnaround [7].

Core Viewpoint - Marvell Technology Inc (NASDAQ:MRVL) is experiencing a short-term bounce despite recent losses, with potential for recovery towards its all-time high of $127.48 [1] Group 1: Stock Performance - MRVL stock is currently trading at $88.13, up 2.7% [1] - The stock was on track for its seventh loss in nine days prior to the recent bounce [1] - Year over year, MRVL is up 11% [3] Group 2: Technical Indicators - The stock has pulled back to its 260-day moving average, being within 0.75 of the trendline's average true range for the first time in at least eight of the past ten trading days [2] - MRVL has flashed a historically bullish signal, with five similar signals over the past three years leading to higher prices 80% of the time, averaging an 11.6% gain one month later [3] - The 14-day relative strength index (RSI) of 22.5 indicates that the stock is in "oversold" territory, suggesting a potential short-term bounce [3]

Core Viewpoint - C4 Therapeutics, Inc. (CCCC) has experienced significant selling pressure, resulting in a 21.9% decline in stock price over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Stock Performance and Technical Indicators - CCCC's stock is currently in oversold territory, indicated by an RSI reading of 26.06, suggesting a potential trend reversal is imminent [5] - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2][3] Group 2: Earnings Estimates and Analyst Sentiment - Analysts have raised earnings estimates for CCCC by 0.3% over the last 30 days, indicating a consensus expectation for better performance [6] - CCCC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which signals a strong potential for a turnaround [7]

Core Viewpoint - Raymond James Financial, Inc. (RJF) is experiencing significant selling pressure, with a recent decline of 11.1% over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, supported by analyst expectations of better-than-previously predicted earnings [1] Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 indicating that a stock may be oversold [2] - RJF's current RSI reading is 29, suggesting that the heavy selling pressure may be exhausting, indicating a potential reversal in trend [5] Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that RJF's earnings estimates for the current year have increased by 1.4% over the last 30 days, which typically correlates with price appreciation [6] - RJF holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [7]

Core Viewpoint - Marvell Technology (MRVL) is experiencing significant selling pressure, with a 20.6% decline over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, supported by analyst consensus for better-than-expected earnings [1][5][6]. Group 1: Stock Performance and Technical Indicators - MRVL's stock has declined 20.6% in the last month, indicating strong selling pressure [1]. - The Relative Strength Index (RSI) for MRVL is currently at 28.73, suggesting it is in oversold territory, which may lead to a trend reversal [5][6]. - A stock is typically considered oversold when its RSI falls below 30, indicating a potential price reversal [2]. Group 2: Analyst Sentiment and Earnings Estimates - There is strong agreement among sell-side analysts that MRVL will report better earnings than previously predicted, with a 0.9% increase in consensus EPS estimates over the last 30 days [6]. - MRVL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a favorable outlook for the stock [7].

Group 1 - Raymond James Financial, Inc. (RJF) has experienced a 12% decline in stock price over the past four weeks, but is now in oversold territory, indicating potential for a trend reversal [1] - The Relative Strength Index (RSI) for RJF is currently at 27.08, suggesting that the heavy selling pressure may be exhausting, which could lead to a price rebound [5] - There is strong consensus among Wall Street analysts that RJF will report better earnings than previously predicted, with a 1.4% increase in consensus EPS estimates over the last 30 days [6] Group 2 - RJF holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [7]